Neuritogenic Effect of Epolactaene Derivatives on Human Neuroblastoma Cells Which Lack High-Affinity Nerve Growth Factor Receptors
- 1 February 1997
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (4) , 391-394
- https://doi.org/10.1021/jm960719a
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Neurotrophic factors: From physiology to pharmacology?Pharmacological Research, 1992
- Neurotrophin-5: A novel neurotrophic factor that activates trk and trkBNeuron, 1991
- trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3Cell, 1991
- The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3Published by Elsevier ,1991
- trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factorCell, 1991
- The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth FactorScience, 1991
- The trk proto-oncogene encodes a receptor for nerve growth factorCell, 1991
- The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domainCell, 1990
- A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequencesNature, 1986